ASHI 2012 – San Juan, Puerto Rico

13/10/2012

Omixon presented its poster, “HLA Typing from Next Generation Sequencing data,” at the 38th Annual Meeting of American Society for Histocompatibility and Immunogenetics in San Juan, Puerto Rico. CEO, Attila Bérces, PhD and VP of Sales and Marketing, Fred Eberlein, attended the conference.

23 Aug 2012 NGS Workshop at Harvard Medical School

24/08/2012

We are grateful for the many researchers and genetists who attended our workshop on August 23, 2012 at Harvard Medical School. Omixon’s CEO, Attila Berces, initiated the workshop with a presentation of how targeted analysis differs from whole genome analysis. The participants were able to test Omixon Target during...

Omixon Organizes a Next-Generation Sequencing Workshop at Harvard Medical School Campus

15/08/2012

We have been highlighting the need for clinical applications in next-generation sequencing and affordable diagnostics for years and that was one of the reasons to organize a workshop at the Joseph B. Martin Conference Center, Harvard Medical School on the 23rd of August between 2 PM and 6PM where you can learn how...

Omixon releases Omixon Target for next generation sequencing data analysis for diagnostics

30/05/2012

Budapest, Hungary – Today, 30 May 2012, Omixon – a genomic software company – announced the commercial release of Omixon Target, a next generation sequencing analysis software for targeted sequencing. Omixon built its new software Target with the vision of helping diagnostic labs to adapt next generation sequencing to replace...

Omixon releases free next generation sequencing simulation and analysis quality control service

17/04/2012

Budapest, Hungary – Today,17 Apr 2012, Omixon announced the release of a free NGS data simulation service that will help to validate data analysis. Analysis errors are still a significant source of false discovery in next generation sequencing (NGS). This free service can help scientists to understand and eliminate analysis...